美国VIVUS  
VIVUS公司是一家生物制药公司，商业化和开发创新下一代疗法，以解决未满足的需求肥胖，睡眠呼吸暂停，糖尿病和性健康，美国，欧洲和世界其他市场。

VIVUS is a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health for U.S., Europe and other world markets. Qsymia is also in phase 2 clinical development for the treatment of type 2 diabetes and obstructive sleep apnea.